logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lizhu Pharmaceutical (01513.HK) spent 3.6914 million yuan on September 16th to repurchase 92,100 A-shares.

date
16/09/2025
Wisdom Financial APP News, Lijun Medicine (01513.HK) announced that it will spend 3.6914 million yuan to repurchase 92,100 shares of A shares on September 16, 2025.
Latest
3 m ago
New stock dark market | Health 160 (02656.HK) dark market closed up 143.9%, earning 4,277.5 Hong Kong dollars per lot.
3 m ago
Runjian Co., Ltd: Wins bid for 1.11 billion yuan China Unicom project.
3 m ago
SHEIN: Launches brand incubation support program "SHEIN Xcelerator"
4 m ago
After Goldman Sachs upgraded Hershey's rating from "sell" to "buy", Hershey's stock price rose 2.8% in pre-market trading.
4 m ago
After Goldman Sachs upgraded Good Times' rating from "sell" to "buy", Good Times' stock price rose 2.8% in pre-market trading.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.